MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s00296-018-3993-5

Медицинская библиотека · Rheumatology international · 2018

Canakinumab treatment in children with familial Mediterranean fever: report from a single center.

Yazılıtaş Fatma, Aydoğ Özlem, Özlü Sare Gülfem, Çakıcı Evrim Kargın, Güngör Tülin, Eroğlu Fehime Kara, Gür Gökçe, Bülbül Mehmet

СтатьяПеревод в очереди

Аннотация

Familial Mediterranean fever (FMF), the most common hereditary autoinflammatory disorder is characterized by recurrent episodes of fever, serositis, arthritis. The major long-term result is amyloidosis. Colchicine remains the principle of the treatment; it not only prevents the acute attacks but also prevents the long-term complications such as amyloidosis; 5-10% of the patients are unresponsive to treatment. Recently new therapeutic options as anti-interleukin 1 agents are successfully used for the patients who do not respond to colchicine treatment. In this study, we retrospectively evaluated 11 pediatric colchicine-resistant FMF patients who were treated with canakinumab. Three of the patients had amyloidosis and two had uveitis. Based on our results, we suggest that canakinumab may be a safe and effective therapy in patients who are resistant to colchicine and even in the patients with amyloidosis. We also suggest that canakinumab might be a safe option for the patients with uveitis.

Для цитирования: Yazılıtaş Fatma, Aydoğ Özlem, Özlü Sare Gülfem, Çakıcı Evrim Kargın, Güngör Tülin, Eroğlu Fehime Kara, Gür Gökçe, Bülbül Mehmet. Canakinumab treatment in children with familial Mediterranean fever: report from a single center.. Rheumatology international. 2018. DOI: 10.1007/s00296-018-3993-5.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.